[
  {
    "ts": "2025-11-15T02:10:45+00:00",
    "headline": "A Look at BioNTech (NasdaqGS:BNTX) Valuation Following Pfizer’s Share Sale Announcement",
    "summary": "BioNTech (NasdaqGS:BNTX) shares caught investors’ attention after Pfizer revealed plans to sell its remaining stake in the company through an overnight block trade. This announcement prompted a wave of trading activity and market discussion. See our latest analysis for BioNTech. BioNTech’s share price has edged down nearly 2% this year, with momentum cooling further in recent months as investors weigh Pfizer’s exit and slowing Covid-19 vaccine revenues against a robust pivot back to oncology...",
    "url": "https://finance.yahoo.com/news/look-biontech-nasdaqgs-bntx-valuation-021045813.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "357905c5-dd2e-398e-aa69-9d29686c5a01",
      "content": {
        "id": "357905c5-dd2e-398e-aa69-9d29686c5a01",
        "contentType": "STORY",
        "title": "A Look at BioNTech (NasdaqGS:BNTX) Valuation Following Pfizer’s Share Sale Announcement",
        "description": "",
        "summary": "BioNTech (NasdaqGS:BNTX) shares caught investors’ attention after Pfizer revealed plans to sell its remaining stake in the company through an overnight block trade. This announcement prompted a wave of trading activity and market discussion. See our latest analysis for BioNTech. BioNTech’s share price has edged down nearly 2% this year, with momentum cooling further in recent months as investors weigh Pfizer’s exit and slowing Covid-19 vaccine revenues against a robust pivot back to oncology...",
        "pubDate": "2025-11-15T02:10:45Z",
        "displayTime": "2025-11-15T02:10:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I2k3PKJsWIEX9xgEQz8JwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tmSjpFKmBAT61w1lG5.BLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/look-biontech-nasdaqgs-bntx-valuation-021045813.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/look-biontech-nasdaqgs-bntx-valuation-021045813.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BNTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-15T10:45:00+00:00",
    "headline": "Is Pfizer Stock a Buy After This $10 Billion Acquisition?",
    "summary": "The company has been on an acquisition spree for years, and this one may be the most important yet.",
    "url": "https://www.fool.com/investing/2025/11/15/is-pfizer-a-buy-after-this-10-billion-acquisition/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f8dd6f8a-cb2f-35ac-bb34-fb9c022505b1",
      "content": {
        "id": "f8dd6f8a-cb2f-35ac-bb34-fb9c022505b1",
        "contentType": "STORY",
        "title": "Is Pfizer Stock a Buy After This $10 Billion Acquisition?",
        "description": "",
        "summary": "The company has been on an acquisition spree for years, and this one may be the most important yet.",
        "pubDate": "2025-11-15T10:45:00Z",
        "displayTime": "2025-11-15T10:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/c0c28e2c75826b6c7bfa730525d2a573",
          "originalWidth": 1400,
          "originalHeight": 934,
          "caption": "Patient self-administering an injector pen.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/up6xZjCHyDKs14Dq39YZPQ--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/c0c28e2c75826b6c7bfa730525d2a573.cf.webp",
              "width": 1400,
              "height": 934,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CsX5hs9eYHLztnAGY6Zj_w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/c0c28e2c75826b6c7bfa730525d2a573.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/15/is-pfizer-a-buy-after-this-10-billion-acquisition/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-stock-buy-10-billion-104500276.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-15T17:30:23+00:00",
    "headline": "Values that Pfizer and Delta CEOs draw on for great leadership",
    "summary": "At Yahoo Finance Invest 2025, Albert Bourla and Ed Bastian shared the values that helped them lead companies through crisis.",
    "url": "https://finance.yahoo.com/news/values-that-pfizer-and-delta-ceos-draw-on-for-great-leadership-173023280.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "3a2a22d4-f353-46ea-89ca-a4ae37ad44c6",
      "content": {
        "id": "3a2a22d4-f353-46ea-89ca-a4ae37ad44c6",
        "contentType": "STORY",
        "title": "Values that Pfizer and Delta CEOs draw on for great leadership",
        "description": "",
        "summary": "At Yahoo Finance Invest 2025, Albert Bourla and Ed Bastian shared the values that helped them lead companies through crisis.",
        "pubDate": "2025-11-15T17:30:23Z",
        "displayTime": "2025-11-15T17:30:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/cf3048d0-c183-11f0-bf7d-04bed62e0d23",
          "originalWidth": 5000,
          "originalHeight": 3333,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j_iGOY_EzynyuthKdDXu5A--~B/aD0zMzMzO3c9NTAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/cf3048d0-c183-11f0-bf7d-04bed62e0d23.cf.webp",
              "width": 5000,
              "height": 3333,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LpuavQX6wri2XIZzLrXJNQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/cf3048d0-c183-11f0-bf7d-04bed62e0d23.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/values-that-pfizer-and-delta-ceos-draw-on-for-great-leadership-173023280.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/values-that-pfizer-and-delta-ceos-draw-on-for-great-leadership-173023280.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DAL"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "HD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]